222 related articles for article (PubMed ID: 17263820)
1. Sézary syndrome in a patient receiving infliximab for ankylosing spondylitis.
Dauendorffer JN; Rivet J; Allard A; Bachelez H
Br J Dermatol; 2007 Apr; 156(4):742-3. PubMed ID: 17263820
[TBL] [Abstract][Full Text] [Related]
2. Diffuse large B-cell lymphoma in a patient with rheumatoid arthritis treated with infliximab and methotrexate.
Nakashima C; Tanioka M; Takahashi K; Miyachi Y
Clin Exp Dermatol; 2008 Jul; 33(4):437-9. PubMed ID: 18485021
[TBL] [Abstract][Full Text] [Related]
3. Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
Braun J; Baraliakos X; Listing J; Fritz C; Alten R; Burmester G; Krause A; Schewe S; Schneider M; Sörensen H; Zeidler H; Sieper J
Ann Rheum Dis; 2008 Mar; 67(3):340-5. PubMed ID: 17967831
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
[TBL] [Abstract][Full Text] [Related]
5. Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy.
Sanli H; Ataman S; Akay BN; Yilmaz A; Yildizlar D; Gürgey E
J Drugs Dermatol; 2007 Aug; 6(8):834-6. PubMed ID: 17763616
[TBL] [Abstract][Full Text] [Related]
6. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab.
Schatteman L; Gyselbrecht L; De Clercq L; Mielants H
J Rheumatol; 2006 Jan; 33(1):82-5. PubMed ID: 16292792
[TBL] [Abstract][Full Text] [Related]
7. Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab.
Paschou S; Voulgari PV; Vrabie IG; Saougou IG; Drosos AA
J Rheumatol; 2009 Feb; 36(2):351-4. PubMed ID: 19040305
[TBL] [Abstract][Full Text] [Related]
8. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
Chan CY; Browning JC; Larsen F; Hsu S
Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
[TBL] [Abstract][Full Text] [Related]
9. Localized Cutaneous Leishmaniasis due to Leishmania infantum in a Patient Treated with Infliximab.
Hakimi S; Rivière S; Del Giudice P; Dereure J; Le Quellec A
Dermatology; 2010; 220(1):63-5. PubMed ID: 19907139
[TBL] [Abstract][Full Text] [Related]
10. IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy.
Jacquet A; Francois H; Frangie C; Yahiaoui Y; Ferlicot S; Micelli C; Mariette X; Durrbach A
Nephrol Dial Transplant; 2009 Nov; 24(11):3540-2. PubMed ID: 19556300
[TBL] [Abstract][Full Text] [Related]
11. Regression of lymphoma after withdrawal of infliximab alone in an infliximab/methotrexate-treated RA patient.
Mo N; Muthu S; O'Sullivan M
Rheumatology (Oxford); 2011 Apr; 50(4):808-10. PubMed ID: 21183450
[No Abstract] [Full Text] [Related]
12. Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitis.
Baraliakos X; Listing J; Rudwaleit M; Brandt J; Alten R; Burmester G; Gromnica-Ihle E; Haibel H; Schewe S; Schneider M; Sörensen H; Zeidler H; Visvanathan S; Sieper J; Braun J
J Rheumatol; 2007 Mar; 34(3):510-5. PubMed ID: 17299842
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis and granuloma formation in patients receiving anti-TNF therapy.
Iliopoulos A; Psathakis K; Aslanidis S; Skagias L; Sfikakis PP
Int J Tuberc Lung Dis; 2006 May; 10(5):588-90. PubMed ID: 16704045
[TBL] [Abstract][Full Text] [Related]
14. Paraparesis due to exacerbation of preexisting spinal pseudoarthrosis following infliximab therapy for advanced ankylosing spondylitis.
Sakaura H; Hosono N; Mukai Y; Fujii R; Yoshikawa H
Spine J; 2006; 6(3):325-9. PubMed ID: 16651229
[TBL] [Abstract][Full Text] [Related]
15. Relapsing cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab.
Mueller MC; Fleischmann E; Grunke M; Schewe S; Bogner JR; Löscher T
Am J Trop Med Hyg; 2009 Jul; 81(1):52-4. PubMed ID: 19556566
[TBL] [Abstract][Full Text] [Related]
16. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
[TBL] [Abstract][Full Text] [Related]
17. Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up.
Gossec L; Le Henanff A; Breban M; Vignon E; Claudepierre P; Devauchelle V; Wendling D; Lespessailles E; Euller-Ziegler L; Sibilia J; Perdriger A; Alexandre C; Dougados M
Rheumatology (Oxford); 2006 Jul; 45(7):859-62. PubMed ID: 16436489
[TBL] [Abstract][Full Text] [Related]
18. Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab.
Baraliakos X; Listing J; Brandt J; Zink A; Alten R; Burmester G; Gromnica-Ihle E; Kellner H; Schneider M; Sörensen H; Zeidler H; Rudwaleit M; Sieper J; Braun J
Arthritis Res Ther; 2005; 7(3):R439-44. PubMed ID: 15899030
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximab.
Conti F; Priori R; Chimenti MS; Coari G; Annovazzi A; Valesini G; Signore A
Arthritis Rheum; 2005 Apr; 52(4):1224-6. PubMed ID: 15818709
[TBL] [Abstract][Full Text] [Related]
20. Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis.
Gengenbacher M; Sebald HJ; Villiger PM; Hofstetter W; Seitz M
Ann Rheum Dis; 2008 May; 67(5):620-4. PubMed ID: 17720725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]